a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）

Clinical trial NCT07128797 · RECRUITING

Trial details

NCT number: NCT07128797
Sponsor: Tasly Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NAFLD (Non-alcoholic Fatty Liver Disease)NASH (Nonalcoholic Steatohepatitis)

Start date: 2025-07-24
Primary completion: 2026-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.